2018
DOI: 10.1002/epi4.12276
|View full text |Cite
|
Sign up to set email alerts
|

Clinically indicated electrical stimulation strategies to treat patients with medically refractory epilepsy

Abstract: SummaryFocal epilepsies represent approximately half of all diagnoses, and more than one‐third of these patients are refractory to pharmacologic treatment. Although resection can result in seizure freedom, many patients do not meet surgical criteria, as seizures may be multifocal in origin or have a focus in an eloquent region of the brain. For these individuals, several U.S. Food and Drug Administration (FDA)–approved electrical stimulation paradigms serve as alternative options, including vagus nerve stimula… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 179 publications
(447 reference statements)
0
7
0
Order By: Relevance
“…Medial septum E-stim has been suggested for clinical studies after the finding that theta rhythm medial septum stimulation reduces seizure susceptibility (Fisher, 2015;Izadi et al, 2018). Together with the previous findings on open-loop stimulation of the medial septum (Miller et al, 1994;Izadi et al, 2019), our results indicate that a single electrode in the medial septum can be used for dual purposes: seizure termination via closedloop seizure rhythm-driven stimulation during ictal periods, and seizure prevention via open-loop theta rhythm stimulation during pre-ictal seizure-initiation periods.…”
Section: Possible Future Clinical Applicationmentioning
confidence: 99%
“…Medial septum E-stim has been suggested for clinical studies after the finding that theta rhythm medial septum stimulation reduces seizure susceptibility (Fisher, 2015;Izadi et al, 2018). Together with the previous findings on open-loop stimulation of the medial septum (Miller et al, 1994;Izadi et al, 2019), our results indicate that a single electrode in the medial septum can be used for dual purposes: seizure termination via closedloop seizure rhythm-driven stimulation during ictal periods, and seizure prevention via open-loop theta rhythm stimulation during pre-ictal seizure-initiation periods.…”
Section: Possible Future Clinical Applicationmentioning
confidence: 99%
“…SDDs can also improve endpoint reporting in anti-seizure device (ASD) clinical trials. The most common ASDs employ targeted brain stimulation to reduce the occurrence and severity of seizures, often in refractory epilepsy patient populations [80,81]. Prominent ASDs include a responsive neurostimulation system (RNS), vagus nerve stimulation (VNS) devices, and deep brain stimulation (DBS) devices [80].…”
Section: Additional Clinical Trial Applications Of Sddsmentioning
confidence: 99%
“…The most common ASDs employ targeted brain stimulation to reduce the occurrence and severity of seizures, often in refractory epilepsy patient populations [80,81]. Prominent ASDs include a responsive neurostimulation system (RNS), vagus nerve stimulation (VNS) devices, and deep brain stimulation (DBS) devices [80]. Similarly to ASM efficacy, ASD effectiveness is currently evaluated by utilizing PROMs to assess changes in seizure frequency [76].…”
Section: Additional Clinical Trial Applications Of Sddsmentioning
confidence: 99%
“…For example, external stimulating currents or external electric fields can affect the excitability of nervous system and the generation and conduction of nervous system information [25][26][27]. On the other hand, electrical stimulation has become an emerging means of treating neuropsychiatric diseases [28,29]. More and more bodies of evidence show that regulation and improvement of brain function can be achieved by changing the amplitude, frequency, and other parameters of stimulation [30,31].…”
Section: Introductionmentioning
confidence: 99%